Guide for PI/Department RPPR Preparation and Submission through NIH eRA Commons

Purpose

UT OSP will delegate submission of RPPRs to PIs for awards issued under Streamlined Noncompeting Award Process (SNAP) awards. This page provides UT-specific instructions for PIs and Departments for completing and submitting the RPPR to NIH for SNAP awards. It is intended to supplement the NIH RPPR Instruction Guide and NIH RPPR Information Page that should be referenced for navigation and other eRA Commons system questions.

PIs that work closely with Department Research Administrators are eligible to obtain delegation to submit in RPPRs in eRA Commons. Department Administrators should submit an ERA Ticket to OSP to gain this access for their PI(s).

To submit a request:

  • Go to the ERA Ticket page
  • Select “Request System Access/Info”
  • Provide a date by which the request is needed (minimum 72 hours)
  • Enter EID for PI that will obtain submit access (Submit one ticket per person for which access is required.)
  • Under Activate System Access/Provide System Related Information
    • Select “eRA Commons (public.era.nih.gov)”
    • Select “Access to submit RPPRs directly to NIH on behalf of a PI”
    • Select This request is to help initiate: “A Research Performance Progress Report (RPPR)”
    • Use comments field to provide additional details
  • Click “Submit”
  • OSP will update your ERA Ticket once access is granted or if additional information is required. Please check your inbox for notifications regarding updates to your request.

The Notice of Award (NOA) will specify whether an award is subject to SNAP in Section III – Terms and Conditions. “K” awards and “R” awards (excluding R35s) are commonly issued under SNAP.

All RPPRs for non-SNAP awards must be routed to OSP for submission to NIH.

Only the PD/PI or the PD/PI delegate may initiate the RPPR. For Multiple PI projects, only the Contact PI or the PD/PI of the Contact PI may initiate the report.

OSP Tip: Two commons reasons that NIH requests corrections to submitted RPPRs is due to personnel effort and unobligated balance information entered incorrectly. As you complete your RPPR, please double check Sections D and G.10 are answered correctly to ensure NIH approves your RPPR and your non-competing award is issued without delay.

To initiate, choose from one of two ways to access the RPPR:

  1. Access RPPR from Status:
    1. Select the Status tab from the Commons menu options.
    2. Select the List of Applications/Grants link from the Status screen or from the menu options.
    3. From the List of Applications/GrantScreen, locate the applicable grant and select the RPPR link from the Action column.The link remains available under the RPPR for the current reporting year until it is submitted.
  2. Access from RPPR tab:
    1. Select RPPR tab from the Commons menu options.
    2. Select the appropriate grant by clicking the hyperlink in the Grant Number column to access the RPPR.

The RPPR consists of separate screens for each of the sections listed below:

  1. Cover Page
  2. Accomplishments
  3. Products
  4. Participants
  5. Impact
  6. Changes
  7. Special Reporting Requirements
  8. Budget
  9. Outcomes (Interim and Final Progress Reports Only)

You may complete the RPPR sections in any order.

A. Cover Page

Pre-populated information.

Review and if necessary, update the OSP Administrative & Signing Officials:

Administrative Official: Christian Pfeiffer Flores, Assistant Director
Signing Official: Christian Pfeiffer Flores, Assistant Director

B. Accomplishments

This section allows NIH to assess whether satisfactory progress was made during the reporting period.

B.1 What are the major goals of this project?

Fill in the text box. (NIH recommended length up to 1 page. Limit is 8,000 characters or approximately 3 pages.)

Note: Goals are equivalent to specific aims. Significant changes in objectives and scope require prior NIH approval.

The specific aims must be provided in the first non-competing type 5 submission for the award. In subsequent RPPRs, this section will prepopulate with the aims/goals previously entered, and may be amended by answering Yes to question B.1.a.

List the major goals of the project as stated in the approved application or as approved by the agency. If the application lists milestones/target dates for important activities or phases of the project, identify these dates and show actual completion dates or the percentage of completion. Generally, the goals will not change from one reporting period to the next. However, if the awarding agency approved changes to the goals during the reporting period, list the revised goals and objectives. Also explain any significant changes in approach or methods from the agency approved application or plan.

B.1.a Have the major goals changed since the initial competing award or previous report?

Answer either Yes or No.

If Yes, written prior approval from the awarding agency grants official is required for significant changes in the project or its direction. The RPPR is not an appropriate vehicle to request such a change.

B.2 What was accomplished under these goals?

PDF upload – up to 2 pages.

Goals are equivalent to specific aims. In the response, emphasize the significance of the findings to the scientific field. Include the approaches taken to ensure robust and unbiased results.

For this reporting period describe:

  1. major activities;
  2. specific objectives;
  3. significant results, including major findings, developments, or conclusions (both positive and negative); and
  4. key outcomes or other achievements. Include a discussion of stated goals not met. As the project progresses, the emphasis in reporting in this section should shift from reporting activities to reporting accomplishments.

Note: If citing references in this section, please provide a full citation. List all products from this reporting period in section C.

B.3 Competitive Revisions/Administrative Supplements

For this reporting period, is there one or more Revision/Supplement associated with this award for which reporting is required?

Answer Yes or No.

If yes, identify the Revision(s)/Supplements(s) by grant number (e.g., 3R01CA098765-01S1) or title and in the text box (700-character limit) describe the specific aims and accomplishments for each Revision/Supplement funded during this reporting period using

Include any supplements to promote diversity or re-entry, or other similar supplements to support addition of an individual or a discrete project.

B.4 What opportunities for training and professional development has the project provided?

Select "Nothing to Report" or Upload PDF document.

This section is required for all projects that have graduate student workers.

Describe opportunities for training and professional development provided to anyone who worked on the project or anyone who was involved in the activities supported by the project.

  • Training activities are those in which individuals with advanced professional skills and experience assist others in attaining greater proficiency. Training activities may include, for example, courses or one-on-one work with a mentor.
  • Professional development activities result in increased knowledge or skill in one’s area of expertise and may include workshops, conferences, seminars, study groups, and individual study. Include participation in conferences, workshops, and seminars not listed under major activities.

Address these items in the uploaded document:

  • For all projects reporting graduate students and/or postdoctoral participants in Section D., describe whether your institution has established Individual Development Plans (IDPs) for those participants. Do not include the actual IDP, instead include information to describe how IDPs are used, if they are used, to help manage the training for those individuals.
  • For T, F, K, R25, R13, D43 and other awards or award components designed to provide training and professional development opportunities, a response is required. Do not reiterate what is reported under Accomplishments. Limit the response to this reporting period

B.5 How have results been disseminated to communities of interest?

Select "Nothing to Report" or fill out text box.

Reporting the routine dissemination of information (e.g. websites, press releases) is not required. For awards not designed to disseminate information to the public or conduct similar outreach activities (usually the case for most R01, R21 or R03 awards) , you will select "Nothing to Report."

If this question is applicable to your award, describe how the results have been disseminated to communities of interest. Include any outreach activities undertaken to reach members of communities who are not usually aware of these research activities, for the purpose of enhancing public understanding and increasing interest in learning and careers in science, technology, and the humanities.

B.6 What do you plan to do for the next reporting period to accomplish the goals?

Fill in the text box. (NIH recommended length up to 1 page. Limit is 8,000 characters or approximately 3 pages.)

Describe briefly what you plan to do during the next reporting period to accomplish the goals and objectives. Discuss efforts to ensure that the approach is scientifically rigorous and results are robust and unbiased.

Include any important modifications to the original plans. Provide a scientific justification for any changes involving research with human subjects or vertebrate animals. A detailed description of such changes must be provided under Section F. Changes.

C. Products

This section allows NIH to assess and report both publications and other products to Congress, communities of interest, and the public. Limit the response to this reporting period.

C.1 Publications

Are there publications or manuscripts accepted for publication in a journal or other publication (e.g. book, one-time publication, monograph, and preprint) during the reporting period resulting directly from the award?

Grantees must report publications in section C.1 if: (1) the publication was accepted for publication or made public during the reporting period; and (2) the publication directly arises from the award (e.g. the award supported personnel activity that contributed to the publication, such as authorship, consulting with authors, preparing manuscripts, running analyses reported in the publication). Publications listed in other parts of the RPPR will not be tracked as award products.

Publications that fall under the NIH Public Access Policy and are non-compliant still must be reported. The next budget period will not be awarded until the publication(s) are compliant. You must either respond to the non-compliance notification via an email to the NIH Grants Management Specialist and Program Office, or submit a Progress Report Additional Materials (PRAM) through the eRA Commons.

How to Report

  • If there are publications to report select Yes and ensure that the Associate with this RPPR box is checked as appropriate.
  • If there are no publications to report select No.

For questions or assistance regarding the NIH Public Access Policy, please contact UT Libraries.

Additional information and instructions may be found in the NIH RPPR Instruction Guide on Pages 76-78.

C.2 Website(s) or other internet site(s).

For awards not designed to create or maintain one or more websites, select "Nothing to Report."

A description is only required for awards designed to create or maintain one or more websites.

List the URL for any Internet site(s) that disseminates the results of the research activities. Provide a short description of each site.

C.3 Technologies or techniques

Select from list or click “Nothing to Report.”

Identify technologies or techniques that have resulted from the research activities. Describe the technologies or techniques and how they are being shared.

C.4 Inventions, patent applications and/or licenses

Have inventions, patent applications and/or licenses resulted from the award during this reporting period?

Select Yes or No.

If yes, has this information been previously provided to the PHS or to the official responsible for patent matters at the grantee organization?

Report inventions through iEdison.

C.5 Other products and resources

C.5.a Other products

Select from list or click “Nothing to Report.”

Identify any other significant products that were developed under this project. Describe the product and how it is available to share with the research community. Do not repeat information provided above.

Examples of other products are: audio or video products; data and research material (e.g., cell lines, DNA probes, animal models); databases; educational aids or curricula; instruments or equipment; models; protocols; and software or netware.

C.5.b Resource sharing

Fill in text box or click “Nothing to Report.”

PD/PIs and grantee organizations are expected to make the results and accomplishments of their activities available to the research community and to the public at large.

If the initial research plan addressed, or the terms of award require, a formal plan for sharing final research data, model organisms, Genome Wide Association Studies data, or other such project-specific data, describe the progress in implementing that plan. For sharing model organisms, include information on the number of requests received and number of requests fulfilled during this reporting period. If the sharing plan is fully implemented, provide a final statement on data sharing.

D. Participants

This section allows NIH to know who has worked on the project to gauge and report performance in promoting partnerships and collaborations.

D.1 What individuals have worked on the project, whether paid or unpaid, including individuals at subcontracting institutions?

Please list individuals, their role (i.e. GRA, Post-doc, Co-I, Technician, etc.), the amount of effort (months) for each appointment, regardless of if effort of the source of funds for the effort (paid or cost-shared).

Show the most senior role in which the person has worked on the project for any significant length of time.

A Commons ID is required for all individuals with a postdoctoral, graduate or undergraduate role. A Commons ID is also required for individuals supported by a Reentry or Diversity Supplement.

If this role is missing an eRA Commons ID, it will generate an error in the system and will prevent submission to NIH.

If your UT student/employee needs an eRA Commons ID, submit an ERA Help Ticket to OSP. UT OSP cannot establish Commons IDS for people at other institutions; therefore, individuals at subrecipient institutions will need to contact their own OSP to request Commons IDs.

Any person who did not work for 1 person month or more on the project will not be listed. Round person months up or down to the next whole number. Those who worked less than 0.5 months will be rounded down and thus not included on the report.

Tips for adding Participants in Section D.1:

  • Enter individual’s Commons ID and select “Populate from Profile” which will partially populate the individual’s information.
  • After all required information is entered for individual, select the “Add/New” button to add the data to the table. Add/New acts as “Save” for this section.

Additional instructions for the Section D – Participants may be found in Chapter 6 of the NIH RPPR Guide.

D.2 Personnel Updates

D.2.a Level of Effort

Will there be, in the next budget period, either (1) a reduction of 25% or more in the level of effort from what was approved by the agency for the PD/PI(s) or other senior/key personnel named in the Notice of Award, or (2) a reduction in level of effort below the minimum amount of effort required by the Notice of Award?

Select Yes or No.

If Yes, provide an explanation in the text box.

D.2.b New senior/key personnel

Are there, or will there be new senior/key personnel?

Select Yes or No.

If Yes, upload biosketch and other support for all new senior/key personnel.

Senior/key personnel are those identified by the grantee institution as individuals who contribute in a substantive measurable way to the scientific development or execution of the project, whether or not salaries are requested.

All senior/key personnel must have a current FID filed/approved and COI training must be complete before they may begin working on the project. Please contact The Office of Research Support and Compliance if you have any questions concerning this requirement.

D.2.c Changes in Other Support

Has there been a change in the active other support of senior/key personnel since the last reporting period? (i.e. new research support, support that ended, etc.)

Select Yes or No.

Select Yes only if active support has changed for the PD/PI(s) or senior/key personnel (consultants do not have to be included).

If Yes, upload active other support for senior key personnel whose support has changed and indicate what the change has been. List the NIH award for which the progress report is being submitted and include the effort that will be devoted in the next reporting period.

Submission of Other Support information is not necessary if support is pending or for changes in the level of effort for active support reported previously.

D.2.d New other significant contributors

Are there, or will there be, new other significant contributors?

Select Yes or No.

If Yes, upload biosketches for all new other significant contributors.

Other significant contributors are individuals who have committed to contribute to the scientific development or execution of the project, but are not committing any specified measurable effort (i.e., person months) to the project.

D.2.e Will there is be a change in the MPI Leadership Plan for the next budget period?

Select Yes or No.

If Yes, upload a revised MPI Leadership Plan that includes a description of the change(s).

All multiple PD/PI awards have a Leadership Plan that describes the roles and areas of responsibility of the named PD/PIs, the process for making decisions concerning scientific directions, allocation of resources, disputes that may arise, and other information related to the management of the proposed team science project. If there has been any change in the governance and/or organizational structure of the Leadership Plan, provide a description, including communication plans and procedures for resolving conflicts, and any changes to the administrative, technical, and scientific responsibilities of the PD/PIs.

If the progress report includes a change in the contact PD/PI address this change and the impact, if any, the change has on the administrative, technical, and scientific responsibilities of the PD/PIs.

A request to change from a multiple PD/PI model to a single PD/PI model, or a change in the number or makeup of the PD/PIs on a multiple PD/PI award, requires the prior approval of the GMO. The progress report is not the appropriate vehicle to request such a change.

E. Impact

This section is used to describe ways in which the work, findings, and specific products of the project have had an impact during this reporting period.

E.1 Only Applicable to SBIR/STTR -R41, R42, U43 and U44 awards

E.2 What is the impact on physical, institutional, or information resources that form infrastructure?

Fill in text box or click “Nothing to Report.”

If the award is not intended to support physical, institutional, or information resources that form infrastructure, select “Nothing to Report.”

Describe ways, if any, in which the project made an impact, or is likely to make an impact, on physical, institutional, and information resources that form infrastructure, including:

  • physical resources (such as facilities, laboratories, or instruments);
  • institutional resources (such as establishment or sustenance of societies or organizations); or
  • information resources, electronic means for accessing such resources or for scientific communication, or the like.

E3. Not Applicable to Most Awards

E4. What dollar amount of the award’s budget is being spent in foreign country(ies)?

List amount & country or click “Nothing to Report.”

Provide the dollar amount obligated to first-tier subawards to foreign entities for this reporting period. If you list more than one foreign country, identify the distribution between the countries. Report only cumulative first-tier subawards dollars by country. Do not report foreign travel, purchases, etc., unless part of a first-tier subaward to a foreign country.

F. Changes

This section addresses changes. Significant changes in objectives and scope require prior NIH approval.

F1. Not Applicable to Most Awards

F2. Actual or anticipated challenges or delays and actions or plans to resolve them

Fill in Text box or click “Nothing to Report.”

Describe challenges or delays encountered during the reporting period and actions or plans to resolve them.

Describe only significant challenges that may impede the research (e.g., accrual of patients, hiring of personnel, need for resources or research tools) and emphasize their resolution.

F.3 Significant changes to human subjects, vertebrate animals, biohazards, and/or select agents

Describe significant deviations, unexpected outcomes, or changes in approved protocols for human subjects, vertebrate animals, biohazards and/or select agents during this reporting period.

Remember that significant changes in objectives and scope require prior NIH approval. If there are changes in any of the following areas, check the appropriate box and provide a description of the changes.

F.3.a Human Subjects

Upload PDF attachment or click “No Change.”

If human subject protocols are or will be different from the previous submission, include a description and explanation of how the protocols differ and provide a new or revised Protection of Human Subjects Section as described in the competing application instructions.

F.3.b Vertebrate Animals

Upload PDF attachment or click “No Change.”

If there are or will be significant changes to the uses of vertebrate animals from the previous submission, provide a description of the changes. Examples of changes considered to be significant include, but are not limited to, changing animal species, changing from noninvasive to invasive procedures, new project/performance site(s) where animals will be used, etc. If studies involving live vertebrate animals are planned and were not part of the originally proposed research design, provide a new or revised Vertebrate Animal Section as described in the competing application instructions.

F.3.c Biohazards

Upload PDF attachment or click “No Change.”

If the use of biohazards is or will be different from that in the previous submission, provide a description and explanation of the difference(s).

F.3.d Select Agents

Upload PDF attachment or click “No Change.”

If the possession, use, or transfer of Select Agents is or will be different from that proposed in the previous submission, including any change in the select agent research location and/or the required level of biocontainment, provide a description and explanation of the differences. If the use of Select Agents was proposed in the previous submission but has not been approved by and were not part of the originally proposed research design, provide a description of the proposed use, possession, transfer, and research location as described in the competing application instructions.

G. Special Reporting Requirements

This section addresses agency-specific award terms and conditions, as well as any award specific reporting requirements.

G.1 Special Notice of Award and Funding Opportunity Announcement Reporting

Not applicable to most awards

Address any special reporting requirements specified in the award terms and conditions in the Notice of Award (NoA) or Funding Opportunity Announcement (FOA).

G.2 Not applicable to most awards

G.3 Not applicable to most awards

G.4 Human Subjects

G.4.a Does this project involve human subjects?

Select Yes or No.

If Yes, answer the rest of questions under this section.

Is the research exempt from Federal regulations?
Select Yes or No.
If yes, check appropriate exemption number.

Does this project involve a clinical trial?
Select Yes or No.
If yes, is this an NIH defined Phase III Clinical Trial?

G.4.b Inclusion Enrollment Data

If the project meets the definition of clinical research and requires the reporting of cumulative enrollment of subjects, follow the below steps to update the inclusion data records associated with this award.

Before selecting the Human Subjects link, hit Save on the RPPR to save all your work in Section G. Failure to do so will result in a loss of data on your report.

  • Select Human Subjects link.
  • On the next screen, click on the “HCST Post Submission” tab.
  • Click on “View” to bring up the appropriate study.
  • You will see the existing study has an “Edit” button available. There are additional buttons to add regular or delayed onset studies.
  • Click on the link in Section 2 of the Study Record screen to initiate the Inclusion Enrollment Report.
  • For each Inclusion Enrollment Report (below Section 2.7), you will need to indicate whether an existing dataset or resource will be used and whether the enrollment location type is domestic or foreign.
  • Update the cells in the existing Inclusion Enrollment Report.
  • After updating the IER, click the “Save and Release Lock” button on the bottom of the page. The submission status will update to “Work in Progress.”
  • Select “Ready for submission” on the pull-down menu.
  • This is important: click the “continue without adding a comment button” (if no comments).
  • OSP will get an email saying that the application is ready for approval.
  • OSP will log into ASSIST and find the appropriate application and submit application. ASSIST is the interface with Human Subjects System.
  • After OSP submits the IER, the human subjects cumulative enrollment numbers are connected to the RPPR application.

Additional guidance and information may be found on the NIH eRA Help page.

G.4.c Does this project include one or more applicable clinical trials that must be registered in ClinicalTrials.gov under FDAAA?

Select Yes or No.

If Yes, provide the ClinicalTrials.gov identifier, NCT number (e.g., NCT00654321) for those trials.

G.5 Human Subjects Education Requirement

Are there personnel on this project who are or will be newly involved in the design or conduct of human subjects research?

Select Yes or No.

If Yes, provide the following:

  • names of individuals,
  • title of the human subjects education program completed by each individual, and a one-sentence description of the program (this is usually CITI training).

G.6 Human Embryonic Stem Cell(s)

Does this project involve human embryonic stem cells?

Select Yes or No.

Not applicable to most awards

If Yes, identify the hESC Registration number from the NIH Registry. Only hESC lines listed as approved in the NIH Registry may be used in NIH funded research.

G.7 Vertebrate Animals

Does this project involve vertebrate animals?

Select Yes or No.

G.8 Project /Performance Sites

If there are changes to the project/performance site(s) displayed, edit as appropriate.

Note: OSP’s address, 3925 West Braker Lane, should not be listed as a performance site. Delete if listed and delete any duplicate addresses.

G.9 Foreign component

Add required information or select “No Foreign Component.”

Provide the organization name, country, and description of each foreign component.

Foreign component is defined as a significant scientific activity that was performed outside of the U.S., either by the grantee or by a researcher employed by a foreign organization, whether or not grant funds were expended.

The following grant-related activities are significant and must be reported:

  • involvement of human subjects or research with live vertebrate animals
  • extensive foreign travel by grantee project staff to collect data, or conduct surveys or sampling activities; or
  • any grantee activity that may have an impact on U.S. foreign policy

Examples of other grant-related activities that may be significant are:

  • collaborations with investigators at a foreign site anticipated to result in co-authorship;
  • use of facilities or instrumentation at a foreign site; or
  • receipt of financial support or resources from a foreign entity.

Foreign travel for consultation does not meet the definition of foreign component.

G.10 Estimated unobligated balance

G.10.a Is it anticipated that an estimated unobligated balance (including prior year carryover) will be greater than 25% of the current year’s total approved budget?

Select Yes or No.

The total approved budget equals the current fiscal year award authorization plus any approved carryover of funds from a prior year(s). The numerator equals the total amount available for carryover and the denominator equals the current year’s total approved budget.

If Yes, provide the estimated unobligated balance.

Your department administrator will help determine the anticipated unobligated balance by checking the account balance in RMS and in Define. A best practice is always to check with SPAA to verify balance.

NIH does review the balance and will ask if they see a large balance when this question is answered as “no” in the RPPR. It may delay the release of the next NOA.

G.10.b If yes, provide an explanation for unobligated balance below.

Fill in Text box.

G.10.c If authorized to carryover the balance, provide a general description of how it is anticipated that the funds will be spent. To determine carryover authorization, see the NOA.

Fill in Text box

G.11 Program Income

Is program income anticipated during the next budget period?

Select Yes or No.

If Yes, provide the amount and source(s).

G.12 F&A Costs

Is there a change in performance sites that will affect F&A costs?

Select Yes or No.

If Yes, provide an explanation an explanation in text box.

Reminder: If you are working remotely due to COVID-19, the same IDC rate that was approved at the time your grant or contract was awarded will continue to be applied, even if you and your research staff/trainees are working 100% remotely. The reason the on-campus rate will still be applied is that the research operating costs incurred by your sponsored research activity continue to be incurred even when you are off campus – costs including building leases for your office and research space; permanent infrastructure depreciation; and salaries, health insurance and other benefits for your research administration staff, department finance support, and all the other UT employees who help you execute and administer your research without being directly billed to your grant/contract.

H. Budget [Applicable to non-SNAP awards only]

I. Outcomes - ONLY for Interim and Final RPPRs

This component is used to provide information regarding the cumulative outcomes or findings of the project.

I.1 What were the outcomes of the award?

Outcomes will be made publicly available, thus allowing recipients to provide the general public with a concise summary of the cumulative outcomes or findings of the project at the end of a competitive segment. For NIH awards the length should not exceed half a page.

In addition, for the interim or final RPPR the summary of outcomes or findings of the award must be written in the following format:

  • Is written for the general public in clear, concise, and comprehensible language;
  • Is suitable for dissemination to the general public, as the information may be available electronically;
  • Does not include proprietary, confidential information or trade secrets

Check for Errors

Before submitting the RPPR to NIH, perform an error check to verify the report passes the business rules and systems validations in place. Click the "Check for Errors" button on the RPPR Menu screen. All errors must be corrected prior to submission; the system will prevent submission of an RPPR containing errors.

The system will not prevent submission of an RPPR when a warning message is displayed (warnings are frequently related to a noncompliant publication).

Submit the RPPR to NIH

  • Select the "Submit" button from the RPPR Menu screen.

The Submit RPPR screen displays a certification statement:
In submitting this RPPR, the SO (or PD/PI with delegated authority), certifies to the best of his/her knowledge that the grantee organization is in compliance with the terms and conditions specified in the Notice of Award and Grants Policy Statement, and verifies the accuracy and validity of all administrative, fiscal, and scientific information in the progress report. The SO (or PD/PI with delegated authority) further certifies that the grantee organization will be accountable for the appropriate use of any funds awarded and for the performance of the grant-supported project or activities resulting from the progress report. Deliberate withholding, falsification, or misrepresentation of information could result in administrative actions such as withdrawal of a progress report, suspension and/or termination of an award, debarment of individuals, as well as possible criminal penalties. The grantee institution may be liable for the reimbursement of funds associated with any inappropriate or fraudulent conduct of the project activity.

  • Select the "I Agree" button to sign off on certification.
  • The RPPR is validated for systemic and business rules. If there are any validation failures, they are indicated by error messages on the RPPR Menu screen. Errors must be corrected to submit the RPPR.
  • If all validations pass, the RPPR Menu screen displays the following message: The RPPR has been successfully submitted to PHS.
  • The status updates to Submitted to Agency, and the RPPR Submission date is recorded. The routing history is updated to reflect the submission to Agency.
  • When an RPPR is submitted to Agency, email notification is sent to the PD/PI (Contact PI) on the grant and the SO and AO assigned to the Cover Page of the RPPR.

If NIH requests corrections to a submitted RPPR, they will request the response be submitted through the Public Access Progress Report Additional Materials (PRAM) feature in eRA Commons. For instance, if an RPPR is submitted with non-compliant publications, an auto-generated email will be sent to the PD/PI requesting verification that all publications are in compliant. NIH encourages grantees to use the PRAM feature in eRA Commons. Please contact OSP if you have any questions related to a PRAM request.

  • Annual RPPR – Used to describe a grant’s scientific progress, identify significant changes, report on personnel, and describe plans for the subsequent budget period or year.
  • Interim RPPR – Used when submitting a renewal (Type 2) application. If the Type 2 is not funded, the Interim RPPR will serve as the Final RPPR for the project. If the Type 2 is funded, the Interim RPPR will serve as the annual RPPR for the final year of the previous competitive segment. The data elements collected on the Interim RPPR are the same as for the Final RPPR, including project outcomes.
  • Final RPPR – Used as part of the grant closeout process to submit project outcomes in addition to the information submitted on the annual RPPR, except budget and plans for the upcoming year.
  • NIH awards issued under SNAP, the RPPR is due the 15th of the month prior to the budget end date (45 days prior to budget end date). If the 15th falls on a weekend or Federal holiday, the due date is automatically extended to next business day.
  • NIH awards not issued under SNAP provisions are due two months prior to the budget end date (60 days). These RPPRS must be routed to OSP for submission to NIH.
See more below...